Covington Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Covington Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11	Closed	-$2K	–	793
2020 Q2	$2K	Hold	11	–	–	﹤0.01%	732
2020 Q1	$1K	Hold	11	–	–	﹤0.01%	753
2019 Q4	$2K	Hold	11	–	–	﹤0.01%	860
2019 Q3	$2K	Hold	11	–	–	﹤0.01%	781
2019 Q2	$1K	Hold	11	–	–	﹤0.01%	768
2019 Q1	$2K	Hold	11	–	–	﹤0.01%	707
2018 Q4	$1K	Hold	11	–	–	﹤0.01%	729
2018 Q3	$2K	Hold	11	–	–	﹤0.01%	672
2018 Q2	$7K	Hold	11	–	–	﹤0.01%	653
2018 Q1	$11K	Hold	11	–	–	﹤0.01%	631
2017 Q4	$13K	Hold	11	–	–	﹤0.01%	654
2017 Q3	$2K	Buy	+11	New	+$1.74K	﹤0.01%	689

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Covington Capital Management's AMPE Position: Q3 2020 in Review

Covington Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2020, closing a stake of 11 shares — an estimated $2K sold.

Covington Capital Management first reported a position in AMPE in Q3 2017 and held it in 12 quarters. The position peaked at $13K in Q4 2017. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2020.

Covington Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2020 after selling out during the quarter.
Covington Capital Management sold 11 Ampio Pharmaceuticals Inc. shares in Q3 2020, an estimated $2K.
Covington Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2017 and held it in 12 quarters.
Covington Capital Management's Ampio Pharmaceuticals Inc. position peaked at $13K in Q4 2017.
81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2020.

Based on Covington Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.